Skip to main
Tirzepatide Peptide

An editorial reading desk for the tirzepatide peptide — the 39-residue dual GIP/GLP-1 agonist, read at the receptor and across the trial record.

Tirzepatide Dosage: Label Steps and Trial Results

What does the Tirzepatide label say first?

Tirzepatide is a prescription shot given just under the skin. Here you can read the FDA dose steps, followed by the amounts used in trials. The label starts with 2.5 mg once a week for four weeks. Later, the dose rises in steps. Large trials studied weekly amounts of 5 mg, 10 mg, and 15 mg after that slow rise.

This isn't a dose plan for you. About half of the drug leaves the blood in five days. A small fat piece attached to the peptide, which is a short chain of protein parts, keeps it there that long. Your prescriber chooses your dose.

Which Tirzepatide dosage steps does the label list?

For type 2 diabetes, the FDA label starts with 2.5 mg once a week to help the stomach and bowels adjust, then moves to 5 mg after four weeks. Later rises are 2.5 mg at a time, at least four weeks apart. The dose a person stays on may be 5, 10, or 15 mg [21]. The label lists 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg. Each step lasts at least four weeks [21]. A prescriber looks at blood sugar, weight, side effects, and the reason for treatment before choosing a dose to keep.

For type 2 diabetes, SURPASS trials studied 5 mg, 10 mg, and 15 mg each week [3][5]. SURMOUNT obesity trials used the same three amounts. In those trials, doses began at 2.5 mg and went up during a 20-week rise [5].

For obesity, the label also begins at 2.5 mg. Later steps may reach 15 mg once a week if the person can bear the side effects [12]. Your prescriber decides whether a higher step fits. The slow rise gives your stomach and bowels time to adjust.

What did each Tirzepatide dose change in trials?

In SURMOUNT-1, 2,539 adults who had obesity but did not have diabetes took part in a 72-week trial. Their weight was checked at week 72 [5]:

  • With 5 mg, average weight fell 15.0%. Placebo, a shot with no tirzepatide, cut it by 3.1%.
  • With 10 mg, average weight fell 19.5%. Placebo cut it by 3.1%.
  • With 15 mg, average weight fell 20.9%. Placebo cut it by 3.1%.

In the 40-week SURPASS-2 trial for type 2 diabetes, the three-month blood sugar result fell [3]:

  • With 5 mg, it fell 2.01 points.
  • With 10 mg, it fell 2.24 points.
  • With 15 mg, it fell 2.30 points.

The comparison group received semaglutide 1 mg, another weekly diabetes shot. With semaglutide 1 mg, their result fell 1.86 points [3].

In SURMOUNT-5, each person reached the highest dose they could bear. That was 10 or 15 mg for tirzepatide. Average weight fell 20.2%. With semaglutide, it fell 13.7% over 72 weeks [6].

A later review of SURPASS found an early clue. A blood sugar drop of at least 20% by week 4 often came before better later results. Still, people without that early drop had useful blood sugar and weight loss at every dose [10].

Where is a Tirzepatide injection given?

A Tirzepatide injection goes just under the skin. Trials used the upper arm, belly, or thigh most often. The approved drug isn't swallowed or put into a vein [21].

The drug is sold in one-dose pens and vials. Read the storage directions for the exact product. Some forms need a refrigerator, while the label may allow limited time out of it.

The FDA label says to use a different spot each time. That can reduce skin trouble. From 2022 through early 2025, safety files held more than 19,000 reports about shot sites [21][33]. That count doesn't show how often trouble occurred because it doesn't include the total number of users.

Tirzepatide can leave food in the stomach longer. That matters before a scope test, deep sleep medicine, or an operation. Reviewers discuss longer fasting, a quick stomach ultrasound, or medicine that moves food along [27][28]. Your care team makes the choice. Tell them about the shot before any such test or operation. They can also show you how to use the form you receive.

Why can one Tirzepatide shot last a week?

About half of the tirzepatide in your blood is gone after five days [1]. A small fat piece is attached to its 39-amino-acid chain, or short protein chain. The fat piece helps the drug cling to albumin, a blood protein. The kidneys then clear the drug more slowly [1].

A five-day stay supports one shot a week. After a weekly dose stays the same, the amount in your blood settles within 4–8 weeks [21]. Each rise starts another period of buildup. The first 2.5 mg dose remains low for four weeks to ease stomach and bowel trouble.

In 2020, Urva and his team ran an early Phase 1 study. They compared tirzepatide with an older GLP-1 drug, which copies one gut hormone. Tirzepatide slowed the stomach at first, but this effect eased with continued use [28]. The early slowing matched the first weeks of stomach trouble. The five-day fact doesn't decide your dose.